I want to know what was/is going on. I want a statement by those who were responsible. I want to know the motivation and what's the plan. This, after O'Leary's statement that BDD is no problem for ME... It's very strange. This is so very troubling...Imagine ME under BDD or the like in ICD and/or Snomed - that would be the end. We always could argue with WHO's classification.
And it would be reasonable for Invest in ME to sharply correct Foward-ME for faking signatures.
@Inara
Some clarifications:
The WHO has confirmed in written statements and verbally that there is no intention and no proposal to relocate CFS, ME under the
Mental, behavioural and neurocognitive disorders chapter of ICD-11, which is the chapter in which BDD is located.
The problems with BDD are that the criteria thresholds are very low. Some patient groups, including CFS, ME patients, are potentially vulnerable to misapplication of a diagnosis of BDD, or of receiving
an additional diagnosis of BDD on top of an existing diagnosis.
For ICD-11's defining of BDD, the persistent, distressing symptoms don't have to be "medically unexplained."
BDD can be applied in patients whose symptoms are being caused by general medical conditions and diseases.
For example, it would be possible to have an existing diagnosis of cardiovascular disease + a diagnosis of BDD; or diabetes + BDD; or CFS + BDD,
if the clinician considers the patient also fulfills the criteria for an additional diagnosis of BDD.
There are considerable problems with BDD, just as there are with DSM-5's SSD, on which BDD is based.
Additionally, the term "Bodily distress disorder" is already being used interchangeably with the Fink et al diagnostic term, "Bodily distress syndrome," and this has been the case since at least 2007.
So although BDD and BDS are differently defined and characterized, have different criteria and capture different patient sets, they share a similar name. The ICD-11 BDD term risks being confused and conflated with "Bodily distress syndrome," a disorder construct designed to capture CFS, ME, IBS, FM and some others.
In our joint proposal of March 2017, Mary Dimmock and I requested Exclusions under BDD for CFS and ME. I have also submitted a separate proposal for Exclusions under BDD (and a separate proposal for the Deletion of BDD).
A further point: the only construct under consideration for the core ICD-11 edition to replace most of the ICD-10
Somatoform disorders is
BDD, and this has been the case since BDD was first inserted into the Beta draft, in February 2012.
So it's not a question of: Will the WHO choose BDD or will they choose BSS for the core ICD-11 edition? Or that there is controversy over which they will choose.
They have only ever proposed BDD for the core edition.
For those who can manage a long read, I expand on these problems here:
https://dxrevisionwatch.files.wordpress.com/2018/04/bdd-3.pdf
For SNOMED CT:
BDD was added to SNOMED CT in July 2017. It was added as an exact match for ICD-11's BDD.
SNOMED CT does not have a system of chapters like ICD-10 and ICD-11. Terms in SNOMED CT are arranged under Parent terms.
In SNOMED CT, CFS and ME were located under the
Multisystem disorder parent class - which was OK.
But the
Multisystem disorder parent class was retired for the January 2018 release. (This wasn't specific to CFS, ME - it affected 89 other terms that also lost their
Multisystem disorder parent.)
While I was working with the Countess of Mar, it was agreed that a request for the addition of a new parent term for CFS, ME would be submitted in the name of Forward-ME.
A proposal and rationale was drafted for adding the parent
"Disorder of nervous system" to CFS, ME. This was accepted and in June or July, I should be able to confirm that for the July 31, 2018 release of SNOMED CT International Edition, CFS, ME has been assigned under a new parent,
"Disorder of nervous system."
Once this change has been included in the International Edition, it will be incorporated into the various country extensions, when they release their next updated versions.
(The SNOMED CT terminology system does not have Exclusions like ICD-10 and ICD-11 does, so we could not submit a request for exclusions for CFS, ME.)
And it would be reasonable for Invest in ME to sharply correct Foward-ME for faking signatures.
I need to make it clear that there has been no suggestion of "faking signatures."
The letter I received was signed,
"Mar Chairman, Forward-ME."
The letter does not clarify whether the org reps that are members of Forward-ME had been given an opportunity to review the letter and had reached consensus over its content.
It is also unclear from the letter, whether the intention to dispense with my services as an external adviser had been discussed with the org reps. From the information I have received, so far, it suggests that the org reps (or not all of the org reps) were aware of this decision or that this letter was being sent.
I hope this is clearer, but please let me know if you need further clarifications.